Exor 2021 Annual General Meeting

New appointments in Exor’s committees, composed of independent directors only

Exor and The World-Wide Investment Company Limited join forces to invest in and support Italian consumer goods excellence

Exor’s board of directors approves Half-Year 2021 results

Diego Piacentini joins Exor as Advisor and will become Exor Seeds Chairman

Exor, Ferrari and LoveFrom announce creative partnership

Exor and Covéa sign Memorandum of Understanding for the sale of PartnerRe for $9 Billion (€7.7 Billion)

Exor supports the long-term development of both Iveco and CNH Industrial

2021 Exor Investor Day

Exor and Covéa sign a Definitive Agreement for the sale of PartnerRe for $9 Billion (€7.8 Billion)

Exor N.V. publishes its 2022 Corporate Calendar

Settlement with the Italian Tax Authorities

Exor N.V. announces a share buyback program

Exor’s Board of Directors approves 2021 results

Exor launches Italy Seeds Program to back the most promising entrepreneurs in the country

Exor N.V. acquires 45% of Lifenet Healthcare

Exor appoints Ajay Banga as Chairman

Exor 2022 Annual General Meeting

Acquisition of 45% of Lifenet Healthcare closed

Institut Mérieux and Exor announce a long-term partnership in global healthcare

Exor completes the sale of PartnerRe to Covéa for a total cash consideration of $9.3 billion (€8.6 billion)

Agreement to acquire 10% of Institut Mérieux closed

Exor to transition its stock exchange listing to Euronext Amsterdam to align with the company’s dutch legal structure

Approval by Euronext of admission to listing and trading

Approval by AFM of Listing Prospectus